Cargando…

Multivessel vs. Culprit Vessel-Only Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Patients With Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis

BACKGROUND: The optimal revascularization strategy in patients with ST-segment elevation myocardial infarction (STEMI) complicating by cardiogenic shock (CS) remains controversial. This study aims to evaluate the clinical outcomes of multivessel percutaneous coronary intervention (MV-PCI) compared t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Bingquan, Yang, Huiping, Yu, Wenlong, Zeng, Yunjie, Han, Yue, She, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051032/ https://www.ncbi.nlm.nih.gov/pubmed/35497976 http://dx.doi.org/10.3389/fcvm.2022.735636

Ejemplares similares

Multivessel vs. culprit vessel-only percutaneous coronary intervention in ST-segment elevation myocardial infarction with and without cardiogenic shock
por: Wu, Jing, et al.
Publicado: (2022)

Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction
por: Lang, Jiachun, et al.
Publicado: (2022)

Culprit vessel vs. immediate multivessel vs. out-of-hospital staged intervention for patients with non-ST-segment elevation myocardial infarction and multivessel disease
por: Wang, Chen, et al.
Publicado: (2022)

Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Zhang, Dongfeng, et al.
Publicado: (2014)

Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial
por: Robles-Zurita, Jose Antonio, et al.
Publicado: (2020)

Correction: Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Publicado: (2014)

Correction: Culprit Vessel Only versus Multivessel Percutaneous Coronary Intervention in Patients Presenting with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
Publicado: (2014)

Comparison of clinical outcomes between culprit vessel only and multivessel percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel coronary diseases
por: Ryu, Kwang Sun, et al.
Publicado: (2015)

Culprit vessel only versus “one-week” staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction
por: Ma, Li-Xiang, et al.
Publicado: (2015)

Multivessel Intervention in Myocardial Infarction with Cardiogenic Shock: CULPRIT-SHOCK Trial Outcomes in the PL-ACS Registry
por: Gąsior, Mariusz, et al.
Publicado: (2021)

Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial
por: Quayyum, Zahidul, et al.
Publicado: (2017)

Culprit‐Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial‐Extracorporeal Membrane Oxygenation
por: Choi, Ki Hong, et al.
Publicado: (2023)

Multivessel versus Culprit-Only Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome
por: Pustjens, Tobias F. S., et al.
Publicado: (2022)

Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes
por: Cui, Kongyong, et al.
Publicado: (2019)

Deep Learning Networks Accurately Detect ST-Segment Elevation Myocardial Infarction and Culprit Vessel
por: Wu, Lin, et al.
Publicado: (2022)

Multivessel Versus Culprit Vessel–Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE‐ACS Observational Study
por: Ibrahim, Homam, et al.
Publicado: (2017)

Comparison of Long‐Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct‐Related Artery–Only Revascularization for Patients With ST‐Segment–Elevation Myocardial Infarction With Cardiogenic Shock
por: Lee, Joo Myung, et al.
Publicado: (2019)

Multivessel versus culprit-only PCI in STEMI patients with multivessel disease: meta-analysis of randomized controlled trials
por: Feistritzer, Hans-Josef, et al.
Publicado: (2020)

Culprit vessel only versus complete revascularization following thrombolysis in patients with ST elevation myocardial infraction and multivessel coronary artery disease - A prospective study
por: Jain, Chetan, et al.
Publicado: (2023)

Fibrinolysis vs. primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2021)

The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials
por: Feng, Yujia, et al.
Publicado: (2022)

Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study
por: Yu, Tongtong, et al.
Publicado: (2016)

Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials
por: Xu, Haiyan, et al.
Publicado: (2019)

Percutaneous Intervention in ST-Elevation Myocardial Infarction: Culprit-only or Complete Revascularization?
por: Osório, Ana Paula Susin, et al.
Publicado: (2017)

The CSP (Cardiogenic Shock Prognosis) Score: A Tool for Risk Stratification of Cardiogenic Shock
por: Tien, Yu-Tzu, et al.
Publicado: (2022)

A Rare Case of Cardiogenic Shock Following Severe Multivessel Coronary Vasospasm
por: Rahmani, Reza, et al.
Publicado: (2019)

Systems of Care in Cardiogenic Shock
por: Alvarez Villela, Miguel, et al.
Publicado: (2021)

Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Kim, Inna, et al.
Publicado: (2017)

Optimal Revascularization Strategy in Non–ST‐Segment–Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit‐Only Versus One‐Stage Versus Multistage Revascularization
por: Kim, Min Chul, et al.
Publicado: (2020)

Identification of key genes and mechanisms of epicardial adipose tissue in patients with diabetes through bioinformatic analysis
por: Yang, Huiping, et al.
Publicado: (2022)

Cardiogenic Shock From Global Myocardial Ischemia Induced by Simultaneous Multivessel Coronary Spasm
por: Ahn, Jihye, et al.
Publicado: (2012)

Acute Myocardial Infarction With Cardiogenic Shock Due to Pericardial Constriction and Multivessel Coronary Obstruction
por: Schaikewitz, Matthew F., et al.
Publicado: (2020)

Cardiogenic shock among cancer patients
por: Curtiaud, Anais, et al.
Publicado: (2022)

Defining levels of care in cardiogenic shock
por: Alvarez Villela, Miguel, et al.
Publicado: (2023)

Meta-analysis of extracorporeal membrane oxygenation in combination with intra-aortic balloon pump vs. extracorporeal membrane oxygenation only in patients with cardiogenic shock due to acute myocardial infarction
por: Meertens, Max M., et al.
Publicado: (2023)

Vasoactive pharmacologic therapy in cardiogenic shock: a critical review
por: Kaddoura, Rasha, et al.
Publicado: (2021)

Multiple culprit lesions in ST-segment elevation myocardial infarction with cardiogenic shock: a case of simultaneous thrombosis of two infarct-related arteries
por: Caliskan, R., et al.
Publicado: (2022)

Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis
por: Orban, Martin, et al.
Publicado: (2021)

Complete Versus Culprit-Only Revascularization for ST-Segment Elevation Myocardial Infarction and Multivessel Disease in the 2(nd) Generation Drug-Eluting Stent Era: Data from the INTERSTELLAR Registry
por: Kwon, Sung Woo, et al.
Publicado: (2018)

Impact of Age on Outcomes in Patients With Cardiogenic Shock
por: Kanwar, Manreet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_soar39efb5pu32jh0u135oa9kr